Written by Mohammad Reza Nikravesh, Mehdi Jalali, Hossein Ali Ghafaripoor, Javad Sanchooli, Darioush Hamidi, Shabnam Mohammadi, Masoomeh Seghatoleslam
Parent Category: Year 2012, Volume 4
Category: Year 2012, Volume 4, Issue 3, September-December 2012
Introduction: Nowadays, the important role of stem cells in treatment of many diseases such as stoke is well known. Stem cells derived from either bone marrow or cord bloods are good sources for tissues replacement after post embryonic injuries.
Methods: Fourteen-day-old Wistar rats were used in this study. Rats were subjected to internal carotid artery occlusion for 30 minutes. Then, animals were received intravenously 2×105 Bromo Deoxy Uridine (BRDU) labeled- cord blood stem cells (CBSCs). Rats with hypoxic conditions that were not received any injection were assumed as a sham group. Intact animals who did not receive any injection or surgeries were used as a control group.
Results: Our results were evaluated according to behavioral tests and immunohistochemistry of the brain especially frontal cortex of the control, sham and experimental groups. Behavioral recovery was observed in the experimental group compared to the either the sham or the control group. In addition, histological studies demonstrated a reduction in ischemic cells in the experimental group compared to the sham group.
Conclusion: Intravenous transplantation can be a future line in treatment of infants with hypoxic who are exposed to irreversible damages.
Key words: Stem cell; Ischemic hypoxia; Frontal cortex
Air Max Flair KPUAir Jordan
Volume 13, Issue 1, January-March 2021
The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.
To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here
The most recent editorial (June 2020)
Lessons from COVID-19 pandemic and the Morocco’s success story.
An editorial by Dr. Benksim Abdelhafid (Morocco)
The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.
The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:
TDR Clinical Research and Development Fellowships
Call for applications
Deadline for submission: 7 March 2019, 16:00 (GMT)
TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:
Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019
Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).
About the Instructor
Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: